TACC3 and neoplasm: [12] An additional analysis of 279 head and neck SCC tumor samples from the TGCA dataset (172 oral cavity, 33 oropharynx, 72 laryngeal tumors) and cases of FGFR3-TACC3 were appreciated in two of the HPV+ samples.